Lisata Therapeutics announces new method-of-use patent for certepetide in pancreatic cancer and other solid tumors
LSTA•Lisata Therapeutics announced that a new method-of-use patent has been granted for certepetide in the treatment of pancreatic cancer and other solid tumors.
1. Patent granted
Lisata Therapeutics announced that a new method-of-use patent has been granted for certepetide in the treatment of pancreatic cancer and other solid tumors.
